About inmode ltd. - INMD
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
INMD At a Glance
InMode Ltd.
Tavor Building
Yokneam, Tel Aviv 2069206
| Phone | 972-4-909-6313 | Revenue | 394.82M | |
| Industry | Medical Specialties | Net Income | 181.28M | |
| Sector | Health Technology | Employees | 599 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
INMD Valuation
| P/E Current | 6.633 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 7.425 |
| Price to Sales Ratio | 3.409 |
| Price to Book Ratio | 1.65 |
| Price to Cash Flow Ratio | 10.146 |
| Enterprise Value to EBITDA | 6.687 |
| Enterprise Value to Sales | 1.918 |
| Total Debt to Enterprise Value | 0.01 |
INMD Efficiency
| Revenue/Employee | 659,128.548 |
| Income Per Employee | 302,629.382 |
| Receivables Turnover | 9.618 |
| Total Asset Turnover | 0.479 |
INMD Liquidity
| Current Ratio | 10.228 |
| Quick Ratio | 9.162 |
| Cash Ratio | 8.539 |
INMD Profitability
| Gross Margin | 80.307 |
| Operating Margin | 28.502 |
| Pretax Margin | 36.338 |
| Net Margin | 45.914 |
| Return on Assets | 21.987 |
| Return on Equity | 24.313 |
| Return on Total Capital | 25.473 |
| Return on Invested Capital | 24.12 |
INMD Capital Structure
| Total Debt to Total Equity | 1.111 |
| Total Debt to Total Capital | 1.099 |
| Total Debt to Total Assets | 0.996 |
| Long-Term Debt to Equity | 0.755 |
| Long-Term Debt to Total Capital | 0.746 |